Guan-fu base A

Drug Profile

Guan-fu base A

Latest Information Update: 01 Jul 2003

Price : $50

At a glance

  • Originator Shanghai Institute of Materia Medica
  • Class Alkaloids; Antiarrhythmics; Small molecules
  • Mechanism of Action Sodium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Arrhythmias

Most Recent Events

  • 08 Feb 2000 Profile reviewed but no significant changes made
  • 23 May 1997 New profile
  • 23 May 1997 Preclinical development for Arrhythmias in China (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top